New and Under-utilized Vaccines Implementation (NUVI)

WHO Cervical Cancer Prevention and Control Costing Tool (C4P)

Share

Authors:
World Health Organization

Publication details

Publication date: 2012
Languages: English

Downloads

Overview

WHO IVB has developed a generic costing and planning tool for cervical cancer prevention and control. The tool helps programme planners and managers to generate annual cost projections over a five-year period to scale up activities within the health system. The generic version of the WHO C4P tool allows the user to define different vaccine delivery strategies i.e. through schools, health facilities or campaigns, such as national immunization days. Furthermore it allows sub-national segmentation, extensive modification of inputs, a strategic approach, resource allocation, and recognition of prevailing prices and other key variables. It also provides access to transparent underlying calculations and assumptions. The tool is pre-populated with the required data, and linked to data sources.

Potential target audience of the WHO C4P tool are mediators (i.e. international consultants, technical assistants, trainers) of costing and planning activities, supervisors, sponsors, and managers of costing and planning activities, developers of costing and planning tools, subject matter experts in cervical cancer prevention and control programming and subject matter experts in costing and planning.

A precursor of the tool was successfully field tested in the United Republic of Tanzania and Rwanda. A multidisciplinary team from the Government of Tanzania and non governmental organizations found the tool user-friendly and practical. During a WHO workshop in December 2011 in Geneva the tool was further developed and critically assessed by costing experts representing 5 WHO regions.

A generic version of the tool has also been developed which can be used in different country settings. The WHO C4P tool consists of a HPV Vaccine Module and a Cervical Cancer Screening and Treatment Module. As the latter component is still under development, only the Vaccine Module is available on request by e-mail.